Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

68Ga-PSMA-11 PET/CT for Screening Prior to 177Lu-PSMA-617 Therapy

NCT05547386 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT05547386
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05547386 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
68Ga-PSMA-11 PET/CT for Screening Prior to 177Lu-PSMA-617 Therapy
Lead sponsor
Mayo Clinic
Phase
Phase 3
Overall status
Completed
Start date
May 9, 2022
Completion date
December 31, 2023
Enrollment
163 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

castration-resistant prostate carcinoma, metastatic prostate carcinoma, stage ivb prostate cancer ajcc v8